Identification of MNDA as a new marker for nodal marginal zone lymphoma

[1]  J. Cigudosa,et al.  Splenic Follicular Lymphoma: Clinicopathologic Characteristics of a Series of 32 Cases , 2009, The American journal of surgical pathology.

[2]  J. Armitage,et al.  ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia , 2007, Clinical Cancer Research.

[3]  H. Tagawa,et al.  CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. , 2007, Blood.

[4]  H. Tagawa,et al.  CD 10 (-) MUM 1 ( + ) follicular lymphoma lacks BCL 2 gene translocation and shows characteristic biological and clinical features , 2006 .

[5]  B. Jungnickel,et al.  Human splenic marginal zone B cells lack expression of activation‐induced cytidine deaminase , 2005, European journal of immunology.

[6]  R. Johnstone,et al.  The HIN-200 family: more than interferon-inducible genes? , 2005, Experimental cell research.

[7]  Nerea Martínez,et al.  Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively , 2005, The Journal of pathology.

[8]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.

[9]  L. Staudt,et al.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. , 2004, Blood.

[10]  M. Piris,et al.  Transcriptional Response of T Cells to IFN-α: Changes Induced in IFN-α-Sensitive and Resistant Cutaneous T Cell Lymphoma , 2004 .

[11]  D. Mason,et al.  Immunofluorescent and FISH Analysis of Skin Biopsies , 2004, The American Journal of dermatopathology.

[12]  M. Piris,et al.  Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[13]  S. Pileri,et al.  Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. , 2003, Blood.

[14]  A. Godzik,et al.  Homology modeling provides insights into the binding mode of the PAAD/DAPIN/pyrin domain, a fourth member of the CARD/DD/DED domain family , 2003, Protein science : a publication of the Protein Society.

[15]  Juan F. García,et al.  Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. , 2003, Blood.

[16]  Juan F. García,et al.  Nodal Marginal Zone Lymphoma: A Heterogeneous Tumor: A Comprehensive Analysis of a Series of 27 Cases , 2003, The American journal of surgical pathology.

[17]  Ruchi M. Newman,et al.  Comparative analysis of apoptosis and inflammation genes of mice and humans. , 2003, Genome research.

[18]  E. Campo,et al.  Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. , 2002, Blood.

[19]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[20]  E. Dahl,et al.  The DAPIN family: a novel domain links apoptotic and interferon response proteins. , 2001, Trends in biochemical sciences.

[21]  J C Reed,et al.  PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. , 2001, Trends in biochemical sciences.

[22]  D. Choubey,et al.  Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha. , 2000, Journal of biological regulators and homeostatic agents.

[23]  A. Fischer,et al.  Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.

[24]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[25]  D. Mason,et al.  Double immunofluorescence labelling of routinely processed paraffin sections , 2000, The Journal of pathology.

[26]  R. Miranda,et al.  Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes. , 1999, Human pathology.

[27]  J. Trapani,et al.  Transcription and Growth Regulatory Functions of the HIN-200 Family of Proteins , 1999, Molecular and Cellular Biology.

[28]  R. Briggs,et al.  Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias. , 1990, Leukemia research.

[29]  L. Hnilica,et al.  Properties of a nuclear protein marker of human myeloid cell differentiation. , 1986, The Journal of biological chemistry.

[30]  R C Briggs,et al.  Nonhistone protein antigen profiles of five leukemic cell lines reflect the extent of myeloid differentiation. , 1984, Blood.